MedTrace Logo

Preoperative Chemoradiation for Glioblastoma

NCT02092038 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2015-11-10

No results posted yet for this study

Summary

Trial to determine the safety of neoadjuvant treatment with concurrent temozolomide and radiation therapy, followed by surgery and then further temozolomide.

Conditions

Interventions

DRUG

Temozolomide

Neoadjuvant treatment with concurrent temozolomide and radiation therapy, followed by surgery and then further temozolomide.

RADIATION

partial brain irradiation

Neoadjuvant treatment with concurrent temozolomide and radiation therapy, followed by surgery and then further temozolomide.

PROCEDURE

stereotactic biopsy of brain tumor

will be assessed for tumor type and tumor markers

PROCEDURE

craniotomy and tumor resection

maximal safe resection

Sponsors & Collaborators

  • Tampa General Hospital

    lead OTHER

Principal Investigators

  • Lawrence Berk, MD, PhD · Tampa General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02092038 on ClinicalTrials.gov